TFAP4 and non-small cell lung carcinoma: Although miR-608 does not affect the incidence of NSCLC, miR-608 can target transcription factor AP-4 (TFAP4) via the Hippo-YAP signaling pathway, thereby promoting NSCLC cell apoptosis and inhibiting cell proliferation (28, 76).